PMC:7546122 / 5513-5753
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T26 | 56-62 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T27 | 116-120 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T27 | 0-8 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T48 | 50-55 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T49 | 56-62 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T50 | 116-120 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T51 | 138-142 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 4, 1 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T34 | 0-240 | Sentence | denotes | SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
115 | 0-10 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
116 | 50-55 | Species | denotes | human | Tax:9606 |